Western Acq Ventures Stock (NASDAQ: WAVSU)

Latest news for Western Acq Ventures (NASDAQ:WAVSU) Stock

Western Acquisition Ventures Corp is a blank check company.

Western Acquisition Ventures Corp. - Unit

Western Acquisition Ventures Corp

News

RVYL

RYVYL Enters MoU With A Security Holder For Full Repayment And Termination Of An 8% Senior Convertible Note And Redemption Of Series B Convertible Preferred Stock

<h3>Gainers</h3>
<ul>
<li>Sunlands Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STG#NYSE">STG</a>) shares rose 12.0% to $6.2 during Wednesday's pre-market session. The company's market cap stands at $85.0 million. </li>
<li>Cheetah Net Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) stock increased by 11.69% to $2.77. The company's market cap stands at $8.9 million. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) shares increased by 10.34% to $1.6. The company's market cap stands at $17.7 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) stock rose 8.67% to $0.04. The market value of their outstanding shares is at $3.5 million. </li>
<li>Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) shares rose 7.89% to $10.93. The market value of their outstanding shares is at $139.7 million. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) shares increased by 7.45% to $0.69. The company's market cap stands at $15.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sypris Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYPR#NASDAQ">SYPR</a>) stock declined by 8.9% to $2.04 during Wednesday's pre-market session. The company's market cap stands at $46.9 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock decreased by 8.84% to $0.7. The company's market cap stands at $10.2 million. </li>
<li>Chijet Motor Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJET#NASDAQ">CJET</a>) shares declined by 8.1% to $1.93. The company's market cap stands at $13.5 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) shares decreased by 6.85% to $0.41. The company's market cap stands at $6.0 million. </li>
<li>Mynd.ai (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) shares decreased by 4.91% to $1.55. The company's market cap stands at $70.7 million. </li>
<li>Phoenix Motor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) stock fell 4.39% to $0.26. The market value of their outstanding shares is at $9.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CJET

CTNT

FEBO

MYND

PLCE

RIME

SYPR

VEEE

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) stock moved upwards by 25.1% to $0.73 during Wednesday's pre-market session. The company's market cap stands at $3.6 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) stock rose 21.71% to $0.74. The company's market cap stands at $29.9 million. </li>
<li>Trinity Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) stock increased by 14.21% to $0.92. The company's market cap stands at $25.3 million. </li>
<li>Nutriband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRB#NASDAQ">NTRB</a>) shares increased by 14.2% to $5.95. The company's market cap stands at $66.0 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock moved upwards by 12.54% to $3.05. The company's market cap stands at $17.8 million. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) shares increased by 12.53% to $3.06. The market value of their outstanding shares is at $114.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lisata Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) shares declined by 19.2% to $3.15 during Wednesday's pre-market session. The market value of their outstanding shares is at $26.4 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) stock declined by 14.57% to $0.88. The market value of their outstanding shares is at $3.2 million. </li>
<li>Xilio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>) stock decreased by 11.82% to $1.12. The company's market cap stands at $51.2 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares fell 11.75% to $2.78. The market value of their outstanding shares is at $3.7 million. </li>
<li>Vincerx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) stock decreased by 9.84% to $0.13. The market value of their outstanding shares is at $4.8 million. </li>
<li>Contineum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) stock fell 9.49% to $10.21. The company's market cap stands at $263.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CTNM

DWTX

EVAX

HSDT

LSTA

MTNB

NTRB

TRIB

VINC

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Eshallgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHGO#NASDAQ">EHGO</a>) stock moved upwards by 10.0% to $1.1 during Wednesday's pre-market session. The company's market cap stands at $28.0 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) shares rose 9.67% to $2.72. The company's market cap stands at $36.9 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares increased by 8.53% to $9.16. The company's market cap stands at $275.8 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) shares moved upwards by 7.92% to $4.9. The market value of their outstanding shares is at $5.4 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) stock increased by 7.63% to $3.1. The market value of their outstanding shares is at $296.9 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock increased by 7.03% to $0.97. The market value of their outstanding shares is at $4.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Radiant Logistics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RLGT#AMEX">RLGT</a>) stock fell 15.0% to $6.0 during Wednesday's pre-market session. The company's market cap stands at $281.4 million. </li>
<li>Mynaric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares declined by 12.23% to $0.58. The company's market cap stands at $14.5 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock fell 9.78% to $6.0. The company's market cap stands at $90.5 million. </li>
<li>Ideal Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPWR#NASDAQ">IPWR</a>) stock fell 8.5% to $7.0. The market value of their outstanding shares is at $57.0 million. </li>
<li>Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) stock decreased by 7.74% to $0.45. The company's market cap stands at $11.8 million. </li>
<li>Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) stock fell 6.94% to $8.86. The company's market cap stands at $117.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EHGO

GPUS

GTEC

IPWR

MYNA

PDYN

RLGT

RYDE

SATL

SGBX

VATE

WLGS

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

Truist Securities analyst Jasper Bibb initiates coverage on APi Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>) with a Buy rating and announces Price Target of $45.

Price Target

Initiation

Analyst Ratings

Truist Securities Initiates Coverage On APi Gr with Buy Rating, Announces Price Target of $45

<h3>Gainers</h3>
<ul>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares increased by 16.9% to $1.38 during Wednesday's pre-market session. The company's market cap stands at $50.9 million. </li>
<li>Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) stock increased by 8.15% to $186.65. The market value of their outstanding shares is at $522.0 billion. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares moved upwards by 7.83% to $12.39. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares moved upwards by 7.42% to $2.75. The company's market cap stands at $4.9 million. </li>
<li>Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) stock increased by 7.2% to $108.55. The company's market cap stands at $22.9 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) shares moved upwards by 6.93% to $1.85. The market value of their outstanding shares is at $59.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) stock fell 20.7% to $99.79 during Wednesday's pre-market session. The company's market cap stands at $2.7 billion. The company's, Q3 earnings came out yesterday. </li>
<li>VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) stock declined by 9.0% to $2.73. The market value of their outstanding shares is at $28.6 million. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) stock decreased by 8.17% to $1.8. The market value of their outstanding shares is at $23.7 million. </li>
<li>908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) stock decreased by 7.6% to $2.8. The market value of their outstanding shares is at $97.5 million. </li>
<li>Neonode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEON#NASDAQ">NEON</a>) shares decreased by 7.26% to $7.8. The market value of their outstanding shares is at $130.9 million. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) stock fell 6.86% to $1.63. The market value of their outstanding shares is at $11.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AGYS

AMOD

CETX

LEDS

MASS

MOBX

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

NEON

ORCL

QUBT

VRME

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

OKYO

OKYO Pharma Announce That It Has Received $1.4M In Non-Dilutive Funding

JP Morgan analyst Stephen Tusa maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Overweight and raises the price target from $162 to $165.

JP Morgan Maintains Overweight on 3M, Raises Price Target to $165

Biotech

General

ImmunoPrecise Antibodies Highlights New GLP-1 Therapies Created Using Co.'s LENS Platform

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) are trending downwards as market participants closely monitor whale activity, burn rates and technical signals for <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">the next big move</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.3669</td>
<td>$54.2 billion</td>
<td>-6.7%&nbsp;</td>
<td>+4.4%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00002061&nbsp;&nbsp;</td>
<td>$12.1 billion</td>
<td>-2.5%&nbsp;</td>
<td>-2.2%&nbsp;</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>&nbsp;$0.00001594&nbsp;&nbsp;</td>
<td>$6.7 billion</td>
<td>+1.5%&nbsp;</td>
<td>-6.2%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto analyst Ali Martinez remains optimistic about Dogecoin&#8217;s potential for further upside.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> is still holding above the breakout zone, showing resilience and potential for further upside! <a href="https://t.co/iqYh5py2CC">pic.twitter.com/iqYh5py2CC</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1881771243986092506?ref_src=twsrc%5Etfw">January 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
TraderSZ, however, <a href="https://x.com/trader1sz/status/1882009976279101888">stated</a> that he has paused scaling into DOGE long positions, waiting for a &#8220;proper reclaim of mid-range&#8221; before re-entering. 
Despite this cautious stance, he remains bullish overall.
Meanwhile, trader StrongHedge observed growing alignment in the market with meme coins and beta assets gaining traction. 
He noted that Shiba Inu and Floki are forming bullish divergences on higher timeframes, while Dogecoin continues to demonstrate strength. 
StrongHedge <a href="https://x.com/StrongHedge/status/1881991684579602791">predicts</a> a broader rally as the market stabilizes.
Statistics: Shibburn data shows a 612.8% surge in the past 24 hours, with 3.2 million SHIB removed from circulation. 
Daily transactions on Shibarium remain robust, exceeding 4.7 million since December 2024.
IntoTheBlock data shows Shiba Inu whale transactions and daily active addresses decreased 48.4% and 3.1%, respectively, in a single day.
Martinez cited Santiment data to show whales purchased another 590 million DOGE in the last 24 hours. 
On the other hand, Coinglass data highlights a 5.8% increase in DOGE open interest ($4.9 billion) and a 23.8% jump in derivative trading volume. 
Short and long liquidations are at their lowest since December 2024.
Despite competition from new entrants like TRUMP and MELANIA, Dogecoin <a href="https://x.com/Crypto_Inside_/status/1882017817769492598">retains</a> its dominance among meme coins, ranking second in 24-hour trading volume ($8.36 billion), trailing only TRUMP ($15.6 billion).
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">Meme Coin Supercycle? Dogecoin, Trump, Bonk Futures ETF Applications Filed</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin Down 7%, Shiba Inu Declines 3%: What's Going On?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Canaccord Genuity analyst Caitlin Burrows initiated coverage on Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) with a Buy rating and announced a price target of $24. Orthofix Medical shares closed at $18.36 on Tuesday. <a href="https://www.benzinga.com/quote/OFIX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst James Kirby initiated coverage on Sun Country Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) with an Overweight rating and announced a price target of $23. Sun Country Airlines shares closed at $16.63 on Tuesday. <a href="https://www.benzinga.com/quote/SNCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Lizzie Dove initiated coverage on Viking Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) with a Neutral rating and announced a price target of $49. Viking Holdings shares closed at $48.49 on Tuesday. <a href="https://www.benzinga.com/quote/VIK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst James Condulis initiated coverage on Cytokinetics, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy rating and announced a price target of $80. Cytokinetics shares closed at $45.82 on Tuesday. <a href="https://www.benzinga.com/quote/CYTK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst Gil Blum initiated coverage on Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) with a Buy rating and announced a price target of $9. Absci shares closed at $3.22 on Tuesday. <a href="https://www.benzinga.com/quote/ABSI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CYTK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="592" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22070309/image-149-1024x592.png" alt="" class="wp-image-744560" style="width:540px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22070309/image-149-1024x592.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22070309/image-149-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22070309/image-149-768x444.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/22070309/image-149.png 1128w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43119868/netflix-procter-gamble-and-3-stocks-to-watch-heading-into-wednesday">Netflix, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Wednesday</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

ABSI

CYTK

OFIX

SNCY

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Events

ONCY

Oncolytics Biotech To Present At 2025 ASCO GI Symposium Jan. 23-25

KMDA

Kamada announced that it was awarded a contract with an international organization for the supply of KAMRAB and VARIZIG in Latin America for 2025-2027

WIIM

Procter & Gamble shares are trading higher following better-than-expected Q2 financial results.

Guidance

Procter & Gamble Maintains FY25 Core EPS Guidance Of $6.91-$7.05 vs $6.93 Est.; Maintains Sales Growth Guidance 2-4%

Earnings

Travelers Companies Q4 Book Value Per Share Of $122.97, Up 13% YoY; Adjusted Book Value Per Share Of $139.04, Up 13% YoY

Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported quarterly earnings of $1.34 per share which met the analyst consensus estimate. This is a 12.61 percent increase over earnings of $1.19 per share from the same period last year. The company reported quarterly sales of $10.97 billion which missed the analyst consensus estimate of $11.01 billion by 0.35 percent. This is a 7.16 percent increase over sales of $10.24 billion the same period last year.

Abbott Laboratories Q4 2024 Adj. EPS $1.34, Inline, Sales $10.97B Miss $11.01B Estimate

Teledyne Technologies Expects Q1 Adjusted EPS Of $4.80-$4.90 Vs. $5.03 Estimate; Sees 2025 Adjusted EPS Guidance Of $21.10-$21.50 Vs. $21.58 Estimate

JP Morgan analyst Doug Anmuth maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Overweight and raises the price target from $1000 to $1150.

NFLX

JP Morgan Maintains Overweight on Netflix, Raises Price Target to $1150

In the preceding three months, 12 analysts have released ratings for JFrog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for JFrog, presenting an average target of $36.42, a high estimate of $42.00, and a low estimate of $30.00. This current average reflects an increase of 7.91% from the previous average price target of $33.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1737547263_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive JFrog is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$39.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Ryan Macwilliams</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Jonathan Ruykhaver</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Koji Ikeda</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$42.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Jeff Hickey</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Miller Jump</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Nick Altmann</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$36.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$36.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Jonathan Ruykhaver</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Andrew Sherman</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to JFrog. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of JFrog compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of JFrog's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FROG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on JFrog analyst ratings.</a>
<h2>About JFrog</h2>
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
<h3>JFrog's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: JFrog's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 23.04%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: JFrog's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -21.04%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): JFrog's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -3.11%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): JFrog's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.18%, the company may face hurdles in achieving optimal financial returns.
Debt Management: JFrog's debt-to-equity ratio is below the industry average. With a ratio of 0.02, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FROG

Assessing JFrog: Insights From 12 Financial Analysts

Western Acq Ventures

Comments

Western Acq Ventures

News

Latest news for Western Acq Ventures (NASDAQ:WAVSU) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga